2 years ago
Zetta Genomics Secures £1.9M in Seed Funding for Genomic Data Platform Expansion
Zetta Genomics, a Cambridge, UK-based genomic data technology company, has raised £1.9M in second seed funding
The round was led by Nina Capital with participation from APEX Ventures and Cambridge Enterprise
The funding will be used to accelerate growth of the XetaBase platform and expand operations
The company is planning to encompass 500,000 genomes under management, configure customer success capabilities, deepen bioinformatics and translation expertise, build out engineering capabilities, and grow internationally, with an initial focus on the UK, US, and Spain.
ProblemTechnology
"Analyzing huge amounts of genomic data is slow, expensive, and difficult, hindering research, diagnosis, and the development of genomic medicine."
Solution
"Zetta Genomics built XetaBase, a platform that simplifies genomic data analysis by aggregating, indexing, and enriching secondary data at scale and speed, making it easier and faster to use genomic data to accelerate research, diagnosis, and the development of genomic medicine."